21 May 2013
Keywords: protherics, files, digifab, health, canada, uk, biopharmaceutical
Article | 15 January 2007
UK biopharmaceutical firm Protherics, which is focused on the fields of critical care and cancer, says that it has submitted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 2007
20 May 2013
© 2013 thepharmaletter.com